Charles Schwab
RNXT icon

Charles Schwab’s RenovoRx RNXT Stock Holding History

Charles Schwab’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,232
Closed -$62.5K – 3494
2025
Q3 		$62.5K Hold
49,232
– – ﹤0.01% 3415
2025
Q2 		$65K Hold
49,232
– – ﹤0.01% 3438
2025
Q1 		$48.7K Hold
49,232
– – ﹤0.01% 3403
2024
Q4 		$63.5K Hold
49,232
– – ﹤0.01% 3430
2024
Q3 		$52.2K Hold
49,232
– – ﹤0.01% 3411
2024
Q2 		$55.6K Hold
49,232
– – ﹤0.01% 3505
2024
Q1 		$66K Hold
49,232
– – ﹤0.01% 3343
2023
Q4 		$113K Hold
49,232
– – ﹤0.01% 3338
2023
Q3 		$62K Buy
+49,232
New +$88.6K ﹤0.01% 3389

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Charles Schwab's RNXT Position: Q4 2025 in Review

Charles Schwab sold out of RenovoRx (RNXT) in Q4 2025, closing a stake of 49,232 shares — an estimated $62.5K sold.

Charles Schwab first reported a position in RNXT in Q3 2023 and held it in 9 quarters. The position peaked at $113K in Q4 2023. 33 funds tracked by Wall St. Rank hold RNXT as of Q4 2025.

  • Charles Schwab reported no remaining RenovoRx position as of Q4 2025 after selling out during the quarter.
  • Charles Schwab sold 49,232 RenovoRx shares in Q4 2025, an estimated $62.5K.
  • Charles Schwab first reported a position in RenovoRx in Q3 2023 and held it in 9 quarters.
  • Charles Schwab's RenovoRx position peaked at $113K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held RenovoRx as of Q4 2025.

Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.